Fuzeon (enfuvirtide) Lyophilized Powder for Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) December 2015 ADVERSE REACTIONS Post Marketing Experience Skin and Subcutaneous Tissue Disorders Cutaneous amyloidosis at... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts